Geneos Wealth Management
AMRN icon

Geneos Wealth Management’s Amarin Corp AMRN Stock Holding History

Geneos Wealth Management’s Portfolio AMRN Stock Details AMRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-50
Closed -$682 – 2561
2024
Q2 		$682 Hold
50
– – ﹤0.01% 2023
2024
Q1 		$882 Hold
50
– – ﹤0.01% 2052
2023
Q4 		$861 Sell
50
-25
-33% -$392 ﹤0.01% 2031
2023
Q3 		$1.37K Hold
75
– – ﹤0.01% 1988
2023
Q2 		$1.77K Sell
75
-30
-29% -$770 ﹤0.01% 1942
2023
Q1 		$3.13K Sell
105
-1,237
-92% -$43.4K ﹤0.01% 1825
2022
Q4 		$32.5K Sell
1,342
-35
-3% -$840 ﹤0.01% 1195
2022
Q3 		$30K Sell
1,377
-281
-17% -$7.54K ﹤0.01% 1192
2022
Q2 		$47K Buy
1,658
+42
+3% +$1.81K ﹤0.01% 1304
2022
Q1 		$106K Sell
1,616
-340
-17% -$22.4K ﹤0.01% 1065
2021
Q4 		$131K Sell
1,956
-4,753
-71% -$394K 0.01% 1067
2021
Q3 		$685K Buy
6,709
+193
+3% +$19K 0.03% 493
2021
Q2 		$572K Sell
6,516
-73
-1% -$7.17K 0.02% 531
2021
Q1 		$670K Hold
6,589
– – 0.02% 549
2020
Q4 		$794K Sell
6,589
-518
-7% -$49.9K 0.03% 417
2020
Q3 		$541K Buy
7,107
+67
+1% +$8.03K 0.03% 410
2020
Q2 		$943K Buy
7,040
+2,875
+69% +$396K 0.05% 295
2020
Q1 		$1.1M Buy
4,165
+1,740
+72% +$578K 0.07% 238
2019
Q4 		$1.04M Buy
2,425
+1,681
+226% +$638K 0.06% 291
2019
Q3 		$225K Buy
744
+18
+2% +$6.28K 0.01% 616
2019
Q2 		$281K Buy
726
+505
+229% +$185K 0.02% 561
2019
Q1 		$91K Buy
221
+46
+26% +$16.6K 0.01% 895
2018
Q4 		$46K Sell
175
-37
-17% -$13.5K ﹤0.01% 1132
2018
Q3 		$68K Buy
212
+12
+6% +$906 ﹤0.01% 1040
2018
Q2 		$12K Sell
200
-12
-6% -$743 ﹤0.01% 1626
2018
Q1 		$12K Hold
212
– – ﹤0.01% 1562
2017
Q4 		$17K Hold
212
– – ﹤0.01% 1439
2017
Q3 		$14K Buy
212
+25
+13% +$1.77K ﹤0.01% 1445
2017
Q2 		$15K Hold
187
– – ﹤0.01% 1375
2017
Q1 		$11K Hold
187
– – ﹤0.01% 1442
2016
Q4 		$11K Hold
187
– – ﹤0.01% 1395
2016
Q3 		$11K Hold
187
– – ﹤0.01% 1321
2016
Q2 		$8K Hold
187
– – ﹤0.01% 1385
2016
Q1 		$5K Buy
+187
New +$5.55K ﹤0.01% 1464

Other funds holding AMRN

SCM
Sarissa Capital Management Greenwich, Connecticut $178M AUM 118.43% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
EP
Eversept Partners New York $1.93B AUM 160.8% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SI
SCP Investment Orinda, California $108M AUM 19.38% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
LC
Longitude (Cayman) Grand Cayman, Cayman Islands $314M AUM
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
HKIM
Hayek Kallen Investment Management Fairhope, Alabama $330M AUM 20.05% 1-Year Est. Return

Geneos Wealth Management's AMRN Position: Q3 2024 in Review

Geneos Wealth Management sold out of Amarin Corp (AMRN) in Q3 2024, closing a stake of 50 shares — an estimated $682 sold.

Geneos Wealth Management first reported a position in AMRN in Q1 2016 and held it in 34 quarters. The position peaked at $1.1M in Q1 2020. 158 funds tracked by Wall St. Rank hold AMRN as of Q3 2024.

  • Geneos Wealth Management reported no remaining Amarin Corp position as of Q3 2024 after selling out during the quarter.
  • Geneos Wealth Management sold 50 Amarin Corp shares in Q3 2024, an estimated $682.
  • Geneos Wealth Management first reported a position in Amarin Corp in Q1 2016 and held it in 34 quarters.
  • Geneos Wealth Management's Amarin Corp position peaked at $1.1M in Q1 2020.
  • 158 funds tracked by Wall St. Rank held Amarin Corp as of Q3 2024.

Based on Geneos Wealth Management's 13F filing for Q3 2024, filed 14 Nov 2024.